Vanguard Portfolio Management
CRDF icon

Vanguard Portfolio Management’s Cardiff Oncology CRDF Stock Holding History

Vanguard Portfolio Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.7K Sell
72,057
-365,157
-84% -$580K ﹤0.01% 3129
2026
Q1 		$708K Buy
+437,214
New +$898K ﹤0.01% 2887

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Portfolio Management's CRDF Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Cardiff Oncology (CRDF) stake by 84% in Q2 2026, selling an estimated $580K and leaving 72,057 shares worth $93.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

Vanguard Portfolio Management first reported a position in CRDF in Q1 2026 and has held it in 2 quarters since. The position peaked at $708K in Q1 2026. 104 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Vanguard Portfolio Management held 72,057 shares of Cardiff Oncology worth $93.7K as of Q2 2026.
  • Vanguard Portfolio Management sold 365,157 Cardiff Oncology shares in Q2 2026, an estimated $580K.
  • Cardiff Oncology made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3129 holding.
  • Vanguard Portfolio Management first reported a position in Cardiff Oncology in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Cardiff Oncology position peaked at $708K in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.